In last trading session, IN8bio Inc (NASDAQ:INAB) saw 2.55 million shares changing hands with its beta currently measuring 0.22. Company’s recent per share price level of $0.15 trading at -$0.01 or -8.31% at ring of the bell on the day assigns it a market valuation of $13.31M. That closing price of INAB’s stock is at a discount of -1060.0% from its 52-week high price of $1.74 and is indicating a premium of 13.33% from its 52-week low price of $0.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.96 million shares which gives us an average trading volume of 1.33 million if we extend that period to 3-months.
For IN8bio Inc (INAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.06 in the current quarter.
IN8bio Inc (NASDAQ:INAB) trade information
Upright in the red during last session for losing -8.31%, in the last five days INAB remained trading in the red while hitting it’s week-highest on Thursday, 05/08/25 when the stock touched $0.15 price level, adding 11.76% to its value on the day. IN8bio Inc’s shares saw a change of -42.96% in year-to-date performance and have moved -10.82% in past 5-day. IN8bio Inc (NASDAQ:INAB) showed a performance of -7.85% in past 30-days. Number of shares sold short was 0.48 million shares which calculate 0.57 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -13.22% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 63.86% while estimates for its earnings growth in next 5 years are of 23.77%.
IN8bio Inc (NASDAQ:INAB)’s Major holders
Insiders are in possession of 5.09% of company’s total shares while institution are holding 32.23 percent of that, with stock having share float percentage of 33.95%. Investors also watch the number of corporate investors in a company very closely, which is 32.23% institutions for IN8bio Inc that are currently holding shares of the company. AIGH CAPITAL MANAGEMENT LLC is the top institutional holder at INAB for having 2.13 million shares of worth $1.8 million. And as of 2024-06-30, it was holding 4.7157 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.42 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.1554 of outstanding shares, having a total worth of $1.21 million.
On the other hand, Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 2.09 shares of worth $0.31 million or 2.30% of the total outstanding shares. The later fund manager was in possession of 952.49 shares on Dec 31, 2024 , making its stake of worth around $0.14 million in the company or a holder of 1.05% of company’s stock.
